Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept
Summary Bullous pemphigoid (BP) is one of the most common acquired immunobullous diseases. Rarely, the development of BP is attributed to drug exposure. We present two cases of BP, one triggered by intravenous iodine, and one associated with etanercept treatment in a patient with psoriasis; the firs...
Saved in:
Published in | Clinical and experimental dermatology Vol. 36; no. 8; pp. 871 - 873 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.12.2011
Wiley-Blackwell Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
Bullous pemphigoid (BP) is one of the most common acquired immunobullous diseases. Rarely, the development of BP is attributed to drug exposure. We present two cases of BP, one triggered by intravenous iodine, and one associated with etanercept treatment in a patient with psoriasis; the first time, to our knowledge, that either of these associations has been reported. The recognition of occasional cases of drug‐induced BP such as ours, with timely cessation of the offending agent, may produce rapid clinical improvement with decreased exposure to potent immunosuppressive therapy. |
---|---|
Bibliography: | istex:D181B66269565A8443C012451E945D238E9486B6 ArticleID:CED4102 ark:/67375/WNG-141JRBGG-1 Conflict of interest: none declared. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Case Study-2 ObjectType-Feature-4 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0307-6938 1365-2230 |
DOI: | 10.1111/j.1365-2230.2011.04102.x |